The effects of the growth factor‐antagonist, trapidil, on remyelination in the CNS
- 1 February 1997
- journal article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 23 (1) , 50-58
- https://doi.org/10.1111/j.1365-2990.1997.tb01185.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factorPublished by Elsevier ,2002
- Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells derived from adult rat spinal cord: In vitro characteristics and response to PDGF, bFGF and NT-3Glia, 1996
- The mechanism of growth-regulation of glioma cells by trapidilJournal of Neuro-Oncology, 1995
- Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: Localisation of GD3 ganglioside immunoreactivityJournal of Neuroscience Research, 1993
- Does oligodendrocyte survival depend on axons?Current Biology, 1993
- Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matterJournal of Neurocytology, 1993
- Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: Immunohistochemical studyJournal of Neuroscience Research, 1992
- Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathwaysJournal of Neurosurgery, 1991
- Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cordJournal of Neurocytology, 1991
- Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitroJournal of Neurosurgery, 1990